Small molecule inhibitors of PDGFR/KIT-family RTKs (e.g. imatinib) are routinely being used for the treatment of gastrointestinal stromal tumors (GIST) and some leukemias, but not CRC (10). The gene discussed is PDGFRB; the disease is gastrointestinal stromal tumor.